La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

Gr. Sarantis Salute del bilancio

Salute finanziaria criteri di controllo 6/6

Gr. Sarantis ha un patrimonio netto totale di €353.6M e un debito totale di €70.3M, che porta il suo rapporto debito/patrimonio netto a 19.9%. Le sue attività totali e le sue passività totali sono rispettivamente €553.5M e €199.9M. L'EBIT di Gr. Sarantis è €47.1M rendendo il suo rapporto di copertura degli interessi 65.7. Ha liquidità e investimenti a breve termine pari a €114.0M.

Informazioni chiave

19.9%

Rapporto debito/patrimonio netto

€70.35m

Debito

Indice di copertura degli interessi	65.7x
Contanti	€113.96m
Patrimonio netto	€353.64m
Totale passività	€199.90m
Totale attività	€553.54m

Aggiornamenti recenti sulla salute finanziaria

Nessun aggiornamento

Recent updates

Kyriakos Sarantis Is The Vice Chairman & CEO of Gr. Sarantis S.A. (ATH:SAR) And Just Spent €118k On Shares

Feb 12

Is Gr. Sarantis S.A. (ATH:SAR) A Great Dividend Stock?

Jan 28

Will The ROCE Trend At Gr. Sarantis (ATH:SAR) Continue?

Jan 10

Who Has Been Selling Gr. Sarantis S.A. (ATH:SAR) Shares?

Dec 17

What Does Gr. Sarantis S.A.'s (ATH:SAR) Share Price Indicate?

Dec 04

Analisi della posizione finanziaria

Passività a breve termine: Le attività a breve termine ( €319.3M ) di SAR superano le sue passività a breve termine ( €109.0M ).

Passività a lungo termine: Le attività a breve termine di SAR ( €319.3M ) superano le sue passività a lungo termine ( €90.9M ).

Storia e analisi del rapporto debito/patrimonio netto

Livello di debito: SAR ha più liquidità del suo debito totale.

Riduzione del debito: Il rapporto debito/patrimonio netto di SAR si è ridotto da 20.4% a 19.9% negli ultimi 5 anni.

Copertura del debito: Il debito di SAR è ben coperto dal flusso di cassa operativo ( 84.3% ).

Copertura degli interessi: I pagamenti degli interessi sul debito di SAR sono ben coperti dall'EBIT ( 65.7 x copertura).

Gr. Sarantis Salute del bilancio

Salute finanziaria criteri di controllo 6/6

Informazioni chiave

Aggiornamenti recenti sulla salute finanziaria

Recent updates

Executive Chairman recently bought €110k worth of stock

Price target increased by 14% to €13.93

Dividend increased to €0.22

Now 21% undervalued

New minor risk - Share price stability

Gr. Sarantis S.A. to Report First Half, 2024 Results on Sep 03, 2024

Price target increased by 9.0% to €9.48

Investor sentiment improves as stock rises 19%

Now 24% overvalued after recent price rise

Full year 2023 earnings released: EPS: €0.59 (vs €0.39 in FY 2022)

Gr. Sarantis S.A. to Report Fiscal Year 2023 Results on Mar 11, 2024

Price target increased by 10% to €8.50

Gr. Sarantis S.A., Annual General Meeting, Dec 20, 2023

Gr. Sarantis S.A. to Report Nine Months, 2023 Results on Nov 07, 2023

New major risk - Revenue and earnings growth

Price target increased by 10% to €7.98

First half 2023 earnings released: EPS: €0.29 (vs €0.17 in 1H 2022)

Gr. Sarantis S.A. to Report First Half, 2023 Results on Sep 11, 2023

New minor risk - Shareholder dilution

Full year 2022 earnings released

Price target decreased to €7.60

Less than half of directors are independent

Price target decreased to €7.60

Price target decreased to €7.78

First half 2022 earnings released: EPS: €0 (vs €0.29 in 1H 2021)

Gr. Sarantis S.A. to Report First Half, 2022 Results on Sep 08, 2022

An unknown buyer agreed to acquire 49% stake in ELCA Cosmetics Limited for €55.2 million.

Price target decreased to €8.48

Full year 2021 earnings: EPS misses analyst expectations

Less than half of directors are independent

Gr. Sarantis S.A., Annual General Meeting, May 24, 2022

Gr. Sarantis S.A. to Report Fiscal Year 2021 Results on Apr 29, 2022

CEO & Director recently sold €2.0m worth of stock

Capital Allocation Trends At Gr. Sarantis (ATH:SAR) Aren't Ideal

Investor sentiment deteriorated over the past week

Vice Chairman & CEO recently bought €86k worth of stock

Gr. Sarantis S.A. (ATSE:SAR) announces an Equity Buyback for 4,222,844 shares, representing 6.04% for €63.34 million.

Vice Chairman & CEO recently bought €119k worth of stock

Vice Chairman & CEO recently bought €248k worth of stock

First half 2021 earnings released: EPS €0.29 (vs €0.23 in 1H 2020)

Vice Chairman & CEO recently bought €61k worth of stock

Vice Chairman & CEO recently bought €90k worth of stock

Vice Chairman & CEO recently bought €915k worth of stock

Vice Chairman & CEO recently bought €69k worth of stock

Vice Chairman & CEO recently bought €217k worth of stock

Robust Earnings May Not Tell The Whole Story For Gr. Sarantis (ATH:SAR)

Full year 2020 earnings released: EPS €0.58 (vs €0.57 in FY 2019)

At €8.66, Is It Time To Put Gr. Sarantis S.A. (ATH:SAR) On Your Watch List?

New 90-day low: €8.75

Gr. Sarantis S.A. to Report Fiscal Year 2020 Results on Apr 08, 2021

Vice Chairman & CEO recently bought €96k worth of stock

I Built A List Of Growing Companies And Gr. Sarantis (ATH:SAR) Made The Cut

Kyriakos Sarantis Is The Vice Chairman & CEO of Gr. Sarantis S.A. (ATH:SAR) And Just Spent €118k On Shares

Vice Chairman & CEO recently bought €118k worth of stock

Is Gr. Sarantis S.A. (ATH:SAR) A Great Dividend Stock?

Will The ROCE Trend At Gr. Sarantis (ATH:SAR) Continue?

Who Has Been Selling Gr. Sarantis S.A. (ATH:SAR) Shares?

Vice Chairman & CEO recently bought €51k worth of stock

What Does Gr. Sarantis S.A.'s (ATH:SAR) Share Price Indicate?

Mehmet Yigit Sardan will acquire 15% interest in Sarantis Anadol from Sarantis.

Gr. Sarantis S.A. Not to Provide Financial Guidance for the Fiscal Year of 2020

First half earnings released

Gr. Sarantis S.A. to Report First Half, 2020 Results on Sep 02, 2020

Analisi della posizione finanziaria

Storia e analisi del rapporto debito/patrimonio netto

Bilancio

Scoprire le aziende sane